Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 February 2020 | Story Lacea Loader

During meetings between the management of the University of the Free State (UFS) and the Bloemfontein Campus Student Representative Council (CSRC) the week of 27 January 2020, an agreement regarding accredited and non-accredited accommodation was reached. Although it has been communicated to students on the university’s campuses earlier this week, it is important to clarify the agreement: 

• For 2020, students on the three campuses of the UFS who receive funding from the National Student Financial Aid Scheme (NSFAS) and who live in accredited and non-accredited accommodation, will receive the monthly accommodation allowance that will be paid directly into the student’s bank account.  Please note that the matter of the lease agreement is between the student and the service provider and the UFS does not take responsibility for payments to any supplier. The payments will only be made once funds are received from NSFAS.  

• Registered NSFAS beneficiaries must log in on Self Service and apply online for the private accommodation allowance. The application process requires that the lease agreement should be uploaded on the Self-Service portal. This lease agreement must be signed by both the student and the service provider. 

• Approved private accommodation applicants will receive their private accommodation allowance payment during the first week of each month for a period of 10 months, depending on the date of approval and the rental period.

• If the service provider does not have a lease agreement, students can download a basic lease agreement form here. This form must be signed by the student and the service provider.

• A process will be in place to verify the accommodation during 2020, as required by the Department of Higher Education, Science and Technology (DHET).  This process will start with the completion of the application form for accreditation by the service provider.  The application form can be obtained here.



News Archive

Heart-valve studies receive international recognition
2017-07-11

 Description: Heart-valve studies  Tags: Heart-valve studies  

Prof Francis Smit, Head of the Department of
Cardiothoracic Surgery at the UFS, and Manager of the
Robert WM Frater Cardiovascular Research Centre, with
Kyle Davis, Mechanical Engineer at the centre.

Photo: Rulanzen Martin

Three heart-valve studies which have been developed at the Robert WM Frater Cardiovascular Research Centre at the School of Medicine at the University of the Free State (UFS) were recently presented in Monte Carlo at the conference of the prestigious global Heart Valve Society (HVS).

These studies are all headed by Prof Francis Smit, Head of the Department of Cardiothoracic Surgery at the UFS, and Manager of the Robert WM Frater Cardiovascular Research Centre.
Prof Smit says the HVS is a combination of the former heart-valve societies of Europe and the US. “Studies on heart-valve disease, heart-valve-related products and operations, as well as the design and development of new valves were presented. There are both clinical and development divisions.

He says the study in which the hemodynamics of their redesigned mechanical poppet valve was compared to a commercial bi-leaflet mechanical heart valve, was named as the best poster presentation in the experimental valve development and numerical flow dynamics division. The study, which was presented by Kyle Davis, mechanical engineer at the centre, competed against some of the best heart-valve research units in the world.

The redesigned valve, based on the 1960s Cape Town poppet valve, has the potential to provide a low-cost solution for mechanical heart-valve replacement. It is possible to produce the titanium ring with 3-D printers and is, together with the silicon poppet valve, extremely inexpensive compared to current mechanical valve-manufacturing processes.
The advantages of this valve over current mechanical valves is that, due to the effective and laminar flow characteristics, as well as the simple locking mechanisms, there is a reduced chance of valve thrombosis, and the need for anti-clotting drugs is therefore limited.

It was also confirmed that the new valve more than meets the published FDA (Federal Drug Agency) requirements, which determine the minimum standards of valves for human use in the US.

The redesigned valve also has a very low platelet activation impact, which is responsible for platelet thrombosis and leads to valve thrombosis or strokes. This valve is another heart-valve project by the centre, which is also in the process of evaluating a tri-leaflet polyurethane valve developed by them.


We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept